1.Analysis effects of 30 cases of clavicle fracture treated with locking plate
Chinese Journal of Postgraduates of Medicine 2013;36(z1):34-35
Objective To analyze the curative effects of treating middle-third comminuted fracture of the clavicle with locking plate.Methods Thrity cases with clavicular comminuted fractures were treated with locking plate.Results All patients were followed,the average follow-up period was 12(6-18)months.The patients all healed well.According to neer shoulder function scoring system,the results were excellent in 20 cases,good in 8 cases,fair in 2 cases,the excellent and good rate was 93.3%(28/30).Conclusion The locking plate for clavicular comminuted fractures has advantage of less damage,rigid fixation,high healing rate,low rate of complications and early motion.
2.Analysis clinical of 32 cases of volar locking compression plate fixation for dorsally displaced fractures of distal radiusin
Zongkai HU ; Zhi WANG ; Zhen ZHANG
Chinese Journal of Postgraduates of Medicine 2013;36(z1):61-64
Objective To evaluate a preliminary outcome of volar surgical treatment of dorsally displaced fractures of distal radius with open reduction and internal fixation with T shape locking compression plate.Methods From January 2009 to January 2012,32 cases with dorsally unstable distal radius fractures were treated with open reduction and internal fixation with T shape locking compression plate.Results All patients were followed; the average follow-up period was 12 (8-18) months.The patients all healed well.According to Dienst scoring system,the results were excellent in 23 cases,good in 7 cases,fair in 2 cases,the excellent and good rate was 93.75%(30/32).Conclusions The volar fixation of T shape locking compression plate for dorsally displaced fractures of distal radius has advantage of stable and reliable,high healing rate,low rate of complications and early motion.It is especially suitable for osteoporosis patients.
3.Implementation and assessment of software based on ESAPI compilation structure
Zhiqun WANG ; Bo YANG ; Jie ZHANG ; Lang YU ; Bei WANG ; Wenbo LI ; Gao ZHU ; Xiaoshen WANG ; Maoying LAN ; Xingliu WANG ; Zongkai ZHOU ; Weihua ZHU ; Zhen ZHANG ; Ke HU ; Fuquan ZHANG ; Jie QIU
Chinese Journal of Radiation Oncology 2021;30(11):1173-1177
Objective:To help clinicians simplify the post-processing operations of structures by developing rapid processing software for target area and organs at risk structures based on ESAPI.Methods:SmartStructure script software was developed based on ESAPI, verified and evaluated in clinical work. 10 cases of rectal cancer receiving neoadjuvant radiotherapy, 10 breast cancer treated with postoperative radiotherapy, 10 cervical cancer receiving postoperative radiotherapy, 10 nasopharyngeal carcinoma receiving radical radiotherapy and 10 lung stereotactic body radiotherapy (SBRT) were selected, and different types of tumors had different post-processing operations of structures. In each case, three methods were used for post-processing of structures. In the control group (manual group), normal manual processing was employed. In the experimental group 1(SmaStru-N group), scripts without templates were utilized. In the experimental group 2(SmaStru-P group). scripts combined with templates were adopted. The processing time of the three methods was compared. Clinicians scored the scripting software from multiple aspects and compared the feeling scores of scripting software and manual operation.Results:All three methods can be normally applied in clinical settings. The error rate in the manual group was 7.0%, 3.0% in the SmaStru-N group 0% in the SmaStru-P group, respectively. Compared with the manual method, SmaStru-N shortened the processing time of target area and organs at risk by 60.9% and 93.3% for SmaStru-P. In addition, SmartStructure was superior to manual method in terms of using feeling scores. Clinicians gave lower score for the" applicability" and" simplicity" , and higher score on the" accuracy" and" efficiency" .Conclusions:Compared with conventional manual structure processing method, SmartStructure software can rapidly and accurately process all structures of the target area and organs at risk, and its advantages become more obvious with the increasing number of structures that need to be processed. SmartStructure software can meet clinical requirements, reduce the error rate, elevate processing speed, improve the working efficiency of clinicians, providing basis for the development of adaptive radiotherapy.
4.Multicenter retrospective study of 38 cases with fumarate hydratase deficiency uterine leiomyoma
Xiyao YAN ; Jianlong LIN ; Ruihua TIAN ; Xiuqing WENG ; Li WANG ; Zongkai ZOU ; Xinhua LI ; Xiandong LIN ; Gang CHEN ; Dan HU
Chinese Journal of Obstetrics and Gynecology 2022;57(6):435-441
Objective:To investigate the clinicopathological features of fumarate hydratase (FH) deficiency uterine leiomyoma.Methods:The data of 38 patients with FH deficiency uterine leiomyoma were screened and analyzed. The expressions of FH, S-(2-succino)-cysteine (2SC), desmin, p16, p53, CD 10 and cell proliferation associated nuclear antigen (Ki-67) proteins were detected by immunohistochemistry, and their clinicopathological features were analyzed retrospectively. Results:(1) Clinical features: the median age of the patients was (42.5±7.4) years old. Twenty-one cases (55%) of them were myomas found in physical examination, and the median maximum diameter of the tumor was 6.0 cm (range: 5.0-7.5 cm); myomectomy was performed in 23 cases (61%), total hysterectomy with or without bilateral appendages in 15 cases (39%); laparoscopic surgery in 27 cases (71%), open surgery in 11 cases (29%); none of the patients had renal cell carcinoma. (2) Histological features: atypical nuclear cells were distributed locally or diffusely, eosinophilic nucleoli and intranuclear inclusion bodies could be seen, glass like globules could be seen in the cytoplasm, nuclear division was 0-4/10 high power field (HPF), and antler like blood vessels and pulmonary edema-like changes could be seen in the stroma. Among 38 patients with FH deficiency uterine leiomyoma, FH was negative in 37 cases (97%), and positive in 1 case (3%); 2SC, desmin, p16, p53, CD 10 and Ki-67 showed focal positive expression in 38 cases (100%), including 35 cases (92%) with Ki-67 index<10% and 3 cases (8%) with Ki-67 index ≥10%. (3) Follow-up: 4 cases (11%) recurred, and there was no death. There were significant differences in age, family history, distribution of atypical nuclei and mitosis number between recurrent group and non-recurrent group (all P<0.05). Conclusions:FH deficiency uterine leiomyoma is a rare tumor, which needs pathological examination,immunohistochemical examination and clinical history. Patients younger than 43 years old, with family history, histologically atypical diffuse nuclear distribution and mitotic number ≥3/10 HPF should be alert to the risk of recurrence.